TY  - GEN
AU  - Petit,A M
AU  - Rak,J
AU  - Hung,M C
AU  - Rockwell,P
AU  - Goldstein,N
AU  - Fendly,B
AU  - Kerbel,R S
TI  - Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors
SN  - 0002-9440
PY  - 1998///0102
KW  - Adenocarcinoma
KW  - drug therapy
KW  - Animals
KW  - Antibodies, Monoclonal
KW  - pharmacology
KW  - Breast Neoplasms
KW  - Carcinoma, Squamous Cell
KW  - Dose-Response Relationship, Drug
KW  - Down-Regulation
KW  - drug effects
KW  - Endothelial Growth Factors
KW  - metabolism
KW  - Epidermal Growth Factor
KW  - immunology
KW  - Gene Expression Regulation, Neoplastic
KW  - Humans
KW  - Immunoenzyme Techniques
KW  - Lymphokines
KW  - Mice
KW  - Mice, Nude
KW  - Neoplasm Transplantation
KW  - Neovascularization, Pathologic
KW  - Neutralization Tests
KW  - Receptor, ErbB-2
KW  - Signal Transduction
KW  - physiology
KW  - Tumor Cells, Cultured
KW  - Vascular Endothelial Growth Factor A
KW  - Vascular Endothelial Growth Factors
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S
ER  -